Divi's Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2026. For the fourth quarter, the company reported sales was INR 28,310 million compared to INR 25,850 million a year ago. Revenue was INR 29,860 million compared to INR 26,710 million a year ago. Net income was INR 7,510 million compared to INR 6,620 million a year ago. Basic earnings per share from continuing operations was INR 28.31 compared to INR 24.93 a year ago. Diluted earnings per share from continuing operations was INR 28.31 compared to INR 24.93 a year ago.
For the full year, sales was INR 105,600 million compared to INR 93,600 million a year ago. Revenue was INR 110,670 million compared to INR 97,120 million a year ago. Net income was INR 25,680 million compared to INR 21,910 million a year ago. Basic earnings per share from continuing operations was INR 96.75 compared to INR 82.53 a year ago. Diluted earnings per share from continuing operations was INR 96.75 compared to INR 82.53 a year ago.
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%).
At the end of March 2020, the group has 2 production sites located in India.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
